More about

Esophageal Cancer

News
September 29, 2020
4 min read
Save

Nivolumab may be ‘new standard’ in esophageal, gastroesophageal junction cancers

Adjuvant nivolumab significantly prolonged DFS compared with placebo among patients with resected esophageal and gastroesophageal junction cancer, according to results of the CheckMate 577 trial presented during ESMO Virtual Congress 2020.

News
September 21, 2020
4 min read
Save

Pembrolizumab regimen superior to chemotherapy alone in advanced esophageal cancer

The addition of pembrolizumab to chemotherapy improved OS, PFS and objective response rates among patients with untreated, advanced esophageal and esophagogastric junction adenocarcinoma, results of the phase 3 KEYNOTE-590 study showed.

News
September 04, 2020
1 min read
Save

FDA grants orphan drug designation to KN046 for thymic epithelial tumors

The FDA granted orphan drug designation to KN046 for the treatment of patients with thymic epithelial tumors, according to a manufacturer-issued press release.

News
August 19, 2020
1 min read
Save

Pembrolizumab regimen extends survival in advanced esophageal cancer

The addition of pembrolizumab to first-line chemotherapy extended OS and PFS among patients with locally advanced or metastatic esophageal cancer, according to the agent’s manufacturer.

News
July 21, 2020
3 min read
Save

Gum disease linked to higher risk for gastric, esophageal cancers

A history of gum disease appeared associated with significantly elevated risks for two types of gastrointestinal cancer, according to prospective study results published in Gut.

News
July 10, 2020
1 min read
Save

Esophageal cancer: Endoscopic therapy bests esophagectomy

In late stage I esophageal cancer, endoscopic therapy correlated with better improvements in cancer-specific survival compared with esophagectomy, according to results published in Gastrointestinal Endoscopy

News
June 30, 2020
2 min read
Save

Black patients less likely to undergo surgery for esophageal cancer

Black patients with esophageal cancer had a lower likelihood of receiving surgical intervention for resectable disease than their white counterparts, according to results of a retrospective study published in Journal of Gastrointestinal Surgery.

News
June 11, 2020
1 min read
Save

FDA approves Opdivo for advanced esophageal cancer after chemotherapy

The FDA approved nivolumab for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma after receiving fluoropyrimidine- and platinum-based chemotherapy.

News
April 21, 2020
3 min read
Save

Proton therapy reduces toxicity risk vs. IMRT in locally advanced esophageal cancer

Proton beam therapy appeared to reduce the risk for and severity of adverse events compared with intensity-modulated radiation therapy for patients with locally advanced esophageal cancer, according to results of a randomized phase 2B study published in Journal of Clinical Oncology.

News
March 31, 2020
4 min read
Save

Blood test detects dozens of cancer types, often before symptoms emerge

A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results of the prospective Circulating Cell-free Genome Atlas study published in Annals of Oncology.

View more